SignatureFD’s Recursion Pharmaceuticals RXRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $43.3K | Sell |
8,548
-2,942
| -26% | -$14.9K | ﹤0.01% | 1655 |
|
|
2025
Q1 | $60.8K | Sell |
11,490
-279
| -2% | -$1.48K | ﹤0.01% | 1458 |
|
|
2024
Q4 | $79.6K | Buy |
11,769
+3,651
| +45% | +$24.7K | ﹤0.01% | 1341 |
|
|
2024
Q3 | $53.5K | Buy |
8,118
+472
| +6% | +$3.11K | ﹤0.01% | 1533 |
|
|
2024
Q2 | $57.3K | Buy |
7,646
+32
| +0.4% | +$240 | ﹤0.01% | 1440 |
|
|
2024
Q1 | $75.9K | Buy |
7,614
+3,200
| +72% | +$31.9K | ﹤0.01% | 1337 |
|
|
2023
Q4 | $43.5K | Buy |
4,414
+94
| +2% | +$927 | ﹤0.01% | 1535 |
|
|
2023
Q3 | $33K | Sell |
4,320
-22
| -0.5% | -$168 | ﹤0.01% | 1602 |
|
|
2023
Q2 | $32.4K | Buy |
4,342
+92
| +2% | +$687 | ﹤0.01% | 1656 |
|
|
2023
Q1 | $28.3K | Hold |
4,250
| – | – | ﹤0.01% | 1681 |
|
|
2022
Q4 | $32.8K | Hold |
4,250
| – | – | ﹤0.01% | 1565 |
|
|
2022
Q3 | $45K | Hold |
4,250
| – | – | ﹤0.01% | 1323 |
|
|
2022
Q2 | $35K | Hold |
4,250
| – | – | ﹤0.01% | 1489 |
|
|
2022
Q1 | $30K | Hold |
4,250
| – | – | ﹤0.01% | 1628 |
|
|
2021
Q4 | $73K | Hold |
4,250
| – | – | ﹤0.01% | 1163 |
|
|
2021
Q3 | $98K | Buy |
+4,250
| New | +$98K | ﹤0.01% | 983 |
|